Skip to main content
. 2017 Nov 6;19(Suppl 5):v1–v88. doi: 10.1093/neuonc/nox158

Table 10.

Five-Year Total, Annual Average Totala, and Annual Average Age-Adjusted Incidence Ratesb for Brain and Other Central Nervous System Tumors by Major Histology Grouping, Histology, and Hispanic Ethnicityc, CBTRUS Statistical Report: NPCR and SEER, 2010-2014

Histology All Hispanic White Hispanic Black Hispanic All Non-Hispanic
Five-Year Total Annual Average Rate 95% CI Five-Year Total Annual Average Rate 95% CI Five-Year Total Annual Average Rate 95% CI Five-Year Total Annual Average Rate 95% CI
Tumors of Neuroepithelial Tissue 10,830 2,166 5.03 4.93-5.13 10,019 2,004 5.13 5.03-5.24 284 57 2.70 2.35-3.09 98,415 19,683 6.85 6.80-6.89
Pilocytic astrocytoma 802 160 0.25 0.23-0.27 723 145 0.25 0.23-0.27 30 6 0.17 0.11-0.27 4,447 889 0.39 0.38-0.40
Diffuse astrocytoma 836 167 0.37 0.35-0.40 776 155 0.38 0.36-0.41 16 3 0.12 0.06-0.20 6,957 1,391 0.51 0.50-0.52
Anaplastic astrocytoma 609 122 0.28 0.26-0.31 568 114 0.29 0.27-0.32 -- -- -- -- 5,928 1,186 0.42 0.41-0.43
Unique astrocytoma variants 153 31 0.05 0.04-0.06 146 29 0.06 0.05-0.07 -- -- -- -- 937 187 0.08 0.07-0.08
Malignant 99 20 0.04 0.03-0.05 97 19 0.04 0.03-0.05 -- -- -- -- 636 127 0.05 0.04-0.05
Non-Malignant 54 11 0.02 0.01-0.02 49 10 0.02 0.01-0.02 -- -- -- -- 301 60 0.03 0.02-0.03
Glioblastoma 4,142 828 2.42 2.35-2.50 3,896 779 2.48 2.40-2.57 109 22 1.43 1.15-1.75 52,279 10,456 3.29 3.26-3.32
Oligodendroglioma 391 78 0.16 0.15-0.18 352 70 0.16 0.15-0.18 -- -- -- -- 3,362 672 0.26 0.25-0.27
Anaplastic oligodendroglioma 196 39 0.09 0.08-0.11 184 37 0.09 0.08-0.11 -- -- -- -- 1,522 304 0.11 0.10-0.12
Oligoastrocytic tumors 308 62 0.13 0.12-0.15 279 56 0.13 0.12-0.15 -- -- -- -- 2,681 536 0.20 0.20-0.21
Ependymal tumors 932 186 0.38 0.35-0.40 843 169 0.37 0.35-0.40 21 4 0.20 0.12-0.32 5,884 1,177 0.44 0.43-0.45
Malignant 607 121 0.23 0.21-0.25 552 110 0.23 0.21-0.26 -- -- -- -- 3,458 692 0.26 0.25-0.27
Non-Malignant 325 65 0.14 0.13-0.16 291 58 0.14 0.12-0.16 -- -- -- -- 2,426 485 0.18 0.17-0.19
Glioma malignant, NOS 888 178 0.36 0.33-0.39 813 163 0.36 0.34-0.39 31 6 0.22 0.14-0.33 6,350 1,270 0.49 0.48-0.50
Choroid plexus tumors 148 30 0.05 0.04-0.06 137 27 0.05 0.04-0.06 -- -- -- -- 666 133 0.05 0.05-0.06
Malignant 29 6 0.01 0.01-0.01 25 5 0.01 0.01-0.01 -- -- -- -- 103 21 0.01 0.01-0.01
Non-Malignant 119 24 0.04 0.03-0.05 112 22 0.04 0.04-0.05 -- -- -- -- 563 113 0.05 0.04-0.05
Other neuroepithelial tumors -- -- -- -- -- -- -- -- -- -- -- -- 78 16 0.01 0.00-0.01
Malignant -- -- -- -- -- -- -- -- -- -- -- -- 50 10 0.00 0.00-0.01
Non-Malignant -- -- -- -- -- -- -- -- -- -- -- -- 28 6 0.00 0.00-0.00
Neuronal and mixed neuronal-glial tumors 566 113 0.20 0.18-0.22 506 101 0.20 0.18-0.22 16 3 0.11 0.06-0.20 3,910 782 0.31 0.30-0.32
Malignant 101 20 0.04 0.04-0.05 93 19 0.04 0.04-0.05 -- -- -- -- 792 158 0.06 0.05-0.06
Non-Malignant 465 93 0.16 0.14-0.17 413 83 0.15 0.14-0.17 -- -- -- -- 3,118 624 0.26 0.25-0.27
Tumors of the pineal region 94 19 0.04 0.03-0.04 93 19 0.04 0.03-0.05 -- -- -- -- 621 124 0.05 0.05-0.05
Malignant 52 10 0.02 0.01-0.02 51 10 0.02 0.01-0.03 -- -- -- -- 333 67 0.03 0.02-0.03
Non-Malignant 42 8 0.02 0.01-0.02 42 8 0.02 0.01-0.03 -- -- -- -- 288 58 0.02 0.02-0.02
Embryonal tumors 750 150 0.23 0.22-0.25 688 138 0.24 0.22-0.26 23 5 0.12 0.07-0.19 2,793 559 0.25 0.24-0.25
Tumors of Cranial and Spinal Nerves 2,686 537 1.31 1.25-1.36 2,450 490 1.31 1.26-1.37 65 13 0.67 0.51-0.87 29,314 5,863 1.98 1.96-2.00
Nerve sheath tumors 2,681 536 1.30 1.25-1.36 2,445 489 1.31 1.25-1.36 65 13 0.67 0.51-0.87 29,293 5,859 1.98 1.95-2.00
Malignant 27 5 0.01 0.01-0.02 26 5 0.01 0.01-0.02 -- -- -- -- 202 40 0.01 0.01-0.02
Non-Malignant 2,654 531 1.29 1.24-1.35 2,419 484 1.29 1.24-1.35 65 13 0.67 0.51-0.87 29,091 5,818 1.96 1.94-1.99
Other tumors of cranial and spinal nerves -- -- -- -- -- -- -- -- -- -- -- -- 21 4 0.00 0.00-0.00
Tumors of Meninges 13,381 2,676 8.04 7.90-8.19 12,279 2,456 8.04 7.89-8.19 409 82 5.76 5.17-6.41 130,687 26,137 8.49 8.44-8.54
Meningioma 12,811 2,562 7.79 7.65-7.94 11,758 2,352 7.79 7.64-7.94 395 79 5.66 5.06-6.29 126,883 25,377 8.22 8.17-8.26
Malignant 165 33 0.09 0.08-0.11 155 31 0.09 0.08-0.11 -- -- -- -- 1,582 316 0.10 0.10-0.11
Non-Malignant 12,646 2,529 7.70 7.56-7.85 11,603 2,321 7.69 7.55-7.84 392 78 5.60 5.01-6.24 125,301 25,060 8.11 8.07-8.16
Mesenchymal tumors 176 35 0.08 0.06-0.09 160 32 0.08 0.07-0.09 -- -- -- -- 1,131 226 0.08 0.08-0.09
Primary melanocytic lesions -- -- -- -- -- -- -- -- -- -- -- -- 115 23 0.01 0.01-0.01
Other neoplasms related to the meninges 381 76 0.16 0.15-0.18 350 70 0.17 0.15-0.19 -- -- -- -- 2,558 512 0.18 0.18-0.19
Lymphomas and Hematopoietic Neoplasms 843 169 0.48 0.45-0.52 792 158 0.50 0.46-0.54 17 3 0.17 0.10-0.28 6,895 1,379 0.45 0.44-0.46
Lymphoma 797 159 0.46 0.43-0.50 751 150 0.48 0.44-0.52 16 3 0.16 0.09-0.27 6,684 1,337 0.43 0.42-0.44
Other hematopoietic neoplasms 46 9 0.02 0.01-0.03 41 8 0.02 0.01-0.03 -- -- -- -- 211 42 0.02 0.01-0.02
Germ Cell Tumors and Cysts 296 59 0.10 0.09-0.11 268 54 0.10 0.09-0.11 -- -- -- -- 1,206 241 0.10 0.10-0.11
Germ cell tumors, cysts and heterotopias 296 59 0.10 0.09-0.11 268 54 0.10 0.09-0.11 -- -- -- -- 1,206 241 0.10 0.10-0.11
Malignant 214 43 0.07 0.06-0.08 195 39 0.07 0.06-0.08 -- -- -- -- 806 161 0.07 0.06-0.07
Non-Malignant 82 16 0.03 0.02-0.04 73 15 0.03 0.02-0.04 -- -- -- -- 400 80 0.03 0.03-0.04
Tumors of Sellar Region 9,757 1,951 4.47 4.38-4.57 8,759 1,752 4.43 4.33-4.53 307 61 3.14 2.76-3.56 54,849 10,970 3.92 3.88-3.95
Tumors of the pituitary 9,289 1,858 4.29 4.20-4.38 8,336 1,667 4.24 4.15-4.34 290 58 3.04 2.66-3.45 52,345 10,469 3.73 3.70-3.76
Malignant 29 6 0.01 0.01-0.02 26 5 0.02 0.01-0.02 -- -- -- -- 143 29 0.01 0.01-0.01
Non-Malignant 9,260 1,852 4.28 4.18-4.37 8,310 1,662 4.23 4.13-4.33 289 58 3.03 2.65-3.44 52,202 10,440 3.72 3.69-3.75
Craniopharyngioma 468 94 0.18 0.17-0.20 423 85 0.18 0.17-0.20 17 3 0.11 0.06-0.18 2,504 501 0.19 0.18-0.20
Unclassified Tumors 2,385 477 1.30 1.24-1.36 2,216 443 1.33 1.27-1.39 58 12 0.63 0.45-0.84 18,304 3,661 1.25 1.23-1.26
Hemangioma 795 159 0.37 0.34-0.40 737 147 0.38 0.35-0.41 -- -- -- -- 5,343 1,069 0.39 0.37-0.40
Neoplasm, unspecified 1,572 314 0.92 0.87-0.97 1,463 293 0.94 0.89-1.00 43 9 0.48 0.33-0.67 12,875 2,575 0.85 0.84-0.87
Malignant 569 114 0.37 0.34-0.40 527 105 0.38 0.34-0.41 -- -- -- 0.04-0.23 6,011 1,202 0.38 0.37-0.39
Non-Malignant 1,003 201 0.55 0.51-0.59 936 187 0.57 0.53-0.61 35 7 0.36 0.24-0.53 6,864 1,373 0.47 0.46-0.48
All other 18 4 0.01 0.01-0.02 16 3 0.01 0.00-0.02 -- -- -- -- 86 17 0.01 0.00-0.01
TOTAL d 40,178 8,036 20.73 20.51-20.95 36,783 7,357 20.84 20.61-21.07 1,152 230 13.15 12.30-14.04 339,670 67,934 23.03 22.95-23.11
Malignant 11,769 2,354 5.74 5.63-5.85 10,921 2,184 5.87 5.75-5.99 300 60 2.94 2.56-3.35 107,905 21,581 7.38 7.34-7.43
Non-Malignant 28,409 5,682 14.99 14.80-15.18 25,862 5,172 14.97 14.78-15.17 852 170 10.21 9.46-11.01 231,765 46,353 15.65 15.58-15.71

aAnnual average cases are calculated by dividing the five year total by five.

bRates are per 100,000 and age-adjusted to the 2000 US standard population.

cHispanic ethnicity is not mutually exclusive of race; Classified using the North American Association of Central Cancer Registries Hispanic Identification Algorithm, version 2 (NHIA v2).

dRefers to all brain tumors including histologies not presented in this table.

- Counts and rates are not presented when fewer than 16 cases were reported for the specific histology category. The suppressed cases are included in the counts and rates for totals.

Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results program; CI, confidence interval; NOS, not otherwise specified.